Literature DB >> 11160613

Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.

B Vanheel1, J Van de Voorde.   

Abstract

The possibility that anandamide is an endothelium-derived hyperpolarizing factor was explored in the rat mesenteric vasculature by use of conventional microelectrode techniques. In the main mesenteric artery, anandamide and its more stable analog methanandamide hardly caused a measurable change in membrane potential of the smooth muscle cells, which promptly hyperpolarized to EDHF liberated by acetylcholine. Inhibition of endogenous anandamide breakdown by phenylmethylsulfonyl fluoride did not increase membrane responses to acetylcholine. The CB(1) receptor antagonist SR141716 did not significantly influence EDHF-mediated hyperpolarization except at extremely high concentrations. Smooth muscle cells of third to fourth order branches of the mesenteric artery, which have a more negative resting membrane potential and show smaller responses to acetylcholine, hyperpolarized by about 6 mV to both anandamide and methanandamide, whereas another CB(1) receptor agonist, WIN 55,212-2, had no effect. Mechanical endothelium removal or pre-exposure to SR141716A did not affect anandamide- and methanandamide-induced hyperpolarizations. However, in the presence of capsazepine, a selective vanilloid receptor antagonist, these membrane potential changes were reversed to a small depolarization, whereas EDHF-induced hyperpolarizations were not affected. Pretreating small vessels with capsaicin, causing desensitization of vanilloid receptors and/or depletion of sensory neurotransmitter, completely blocked methanandamide-induced hyperpolarizations. These findings show that anandamide cannot be EDHF. In smooth muscle cells of small arteries, anandamide-induced changes in membrane potential are mediated by vanilloid receptors on capsaicin-sensitive sensory nerves. The different membrane response to the cannabinoids between the main mesenteric artery and its daughter branches might be explained by the different density of perivascular innervation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160613

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  A role for voltage-gated, but not Ca2+-activated, K+ channels in regulating spontaneous contractile activity in myometrium from virgin and pregnant rats.

Authors:  Philip Irving Aaronson; Uzma Sarwar; Stephanie Gin; Uli Rockenbauch; Michelle Connolly; Alexandra Tillet; Sarah Watson; Bing Liu; Rachel Marie Tribe
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

3.  beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels.

Authors:  Detlef Bieger; Kakoli Parai; Carol Ann Ford; Reza Tabrizchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-25       Impact factor: 3.000

4.  Influence of methanandamide and CGRP on potassium currents in smooth muscle cells of small mesenteric arteries.

Authors:  Mélissa Bol; Luc Leybaert; Bert Vanheel
Journal:  Pflugers Arch       Date:  2012-03-14       Impact factor: 3.657

5.  Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.

Authors:  Saoirse E O'Sullivan; David A Kendall; Michael D Randall
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

6.  Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA).

Authors:  Saoirse E O'Sullivan; David A Kendall; Michael D Randall
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

7.  Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries.

Authors:  Marta Baranowska-Kuczko; Hanna Kozłowska; Mirosław Kozłowski; Eberhard Schlicker; Monika Kloza; Arkadiusz Surażyński; Emilia Grzęda; Barbara Malinowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-28       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.